News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
99
Sources here
19
Companies here
8
Search results Stored financial headlines

Active search

99 matching headlines

Ticker or company: CURAMain company stories
Clear

Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary

Curanex Pharmaceuticals Inc (CURX) reported a net loss of $(3.29M) for Q2 2026, with a diluted loss per share of $(0.12), and no revenue as the company remains pre-revenue. This compares to a net loss of $(0.06M) in Q2 2025. The company completed a …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

CURX: Net loss rose to $6.4M as R&D spending increased; cash shortfall raises going concern doubts

Curanex Pharmaceuticals Inc (CURX) reported a net loss of $6.4 million for the first half of 2026, primarily due to increased spending on R&D and administrative costs as its lead drug candidate progresses. The company faces significant going concern doubts as its current cash …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Accuray names two executives to lead transformation efforts

Accuray Incorporated has announced the appointment of Todd Brown as Senior Vice President for a new Enterprise Performance Optimization organization and Sofiane Laoussadi as Senior Vice President, Global Services & Solutions. These appointments are part of the company's "Transformation Phase II" priorities, aimed at …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split

Accuray (NASDAQ: ARAY) is seeking stockholder approval for a significant financing and recapitalization plan, including issuing $55 million in Series A Convertible Preferred Stock and warrants, and a reverse stock split. The plan aims to strengthen liquidity, reduce leverage, and achieve Nasdaq compliance, but …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Acquiring Aurora Cannabis a Good Move for Curaleaf?

Curaleaf Holdings (OTC: CURLF) has been aggressively pursuing Canadian-based cannabis producer Aurora Cannabis (NASDAQ: ACB) for well over a month. However, that hasn't been known to investors until recently, with Curaleaf now launching a hostile takeover attempt, as it claims Aurora hasn't been responding …

CURA main company
Sharemaestro market context Trend signal active 52 weeks +12.3% CURA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Curaleaf sets sights on Aurora Cannabis

©Curaleaf to acquire Aurora Cannabis. (Source: Google Gemini. Generated by AI) In a strategic bid to forge a global cannabis powerhouse, Curaleaf Holdings (TSX:CURA) unveiled its intention to launch a takeover bid for Aurora Cannabis (TSX/NASDAQ:ACB). The proposed offer values Aurora at US$4 per …

CURA main company
Sharemaestro market context Trend signal active 52 weeks +12.3% CURA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Accuray Transfers Listing to Nasdaq Capital Market

Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. This transfer grants the company an additional 180 days, until February 1, 2027, to meet Nasdaq's minimum …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Curanex Pharmaceuticals Inc (CURX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Curanex Pharmaceuticals Inc (CURX), including future EPS and revenue growth estimates. It notes the current stock price, market cap, and offers an overview of the company's financial data, technical forecast, and peer comparison. The forecast data was …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Accuray Announced Transfer or Voluntary Withdrawal of Listing

Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. The company retains its ARAY symbol and has an additional 180 days, until February 1, 2027, to …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Radiation therapy company Accuray will discuss results Aug. 19

Accuray (NASDAQ: ARAY) is scheduled to report its fourth quarter fiscal 2026 financial results on August 19, 2026, for the period ending June 30, 2026. Company management will host a conference call that day at 1:30 p.m. PT / 4:30 p.m. ET to discuss …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neuberger Berman Group (ARAY) discloses 5.48M Accuray shares in 13G/A filing

Neuberger Berman Group LLC and its affiliates have disclosed an amended passive investment in Accuray Inc. (ARAY) via a Schedule 13G/A filing. The group beneficially owns 5,484,393 shares, representing 4.6% of Accuray’s common stock, with shared voting and dispositive power. Neuberger Berman Investment Advisers …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Accuray | SCHEDULE 13G/A: Others

This article consists solely of the title "Accuray | SCHEDULE 13G/A: Others" and the content "Document". It indicates the filing of a Schedule 13G/A, suggesting an amendment to a previous beneficial ownership report for Accuray. However, no detailed information about the filing or the …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026

Accuray Incorporated (ARAY) announced it will report its financial results for the fourth quarter of fiscal year 2026 on August 19, 2026. A conference call hosted by company management will take place at 1:30 p.m. PT/4:30 p.m. ET, with dial-in and webcast details provided …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Accuray Number of Employees 2026 | Employee Count & Headcount Data

Accuray, Inc. (ARAY) had 909 employees worldwide as of March 2026, representing an 8.3% decline from 2023. The company is actively hiring, with 40 active job postings in 2026, though this is a 51.9% decline from 2025. The workforce is concentrated in North America, …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form S-3 Accuray Incorporated For: 31 July By Investing.com

This article from Investing.com announces the filing of Form S-3 by Accuray Incorporated for the period ending July 31. It is a brief administrative notice indicating a regulatory filing has been made by the company. The content primarily consists of navigational elements and market …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to sales forward of Accuray Incorporated – NASDAQ:ARAY

This article provides financial information for Accuray Incorporated (NASDAQ: ARAY), specifically focusing on its price to sales forward metric. It appears to be a data point or a snapshot from a financial platform like TradingView, indicating the value and change of this financial ratio. …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Curanex Pharmaceuticals Inc

This article provides a company overview for Curanex Pharmaceuticals Inc (CURX). It shows the stock price, market capitalization, and indicates that revenue breakdown data by business segment and region have not yet been disclosed by the company. The page primarily serves as a placeholder …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Accuray (ARAY) files S-3 to register 6.8M warrant shares for resale

Accuray Incorporated has filed a Form S-3 shelf registration statement to allow for the resale of up to 6,834,308 shares of common stock by certain lending investors. These shares are issuable upon the exercise of Super Premium, Premium, and Penny Warrants previously granted in …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context